SKYRIZI (RISANKIZUMAB-RZAA) — FDA Approval BLA761105 (ABBVIE INC)
SKYRIZI (RISANKIZUMAB-RZAA) — FDA Approval BLA761105 (ABBVIE INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SKYRIZI; Active ingredients: RISANKIZUMAB-RZAA; Application number: BLA761105.
| Brand name | SKYRIZI |
|---|---|
| Active ingredients | RISANKIZUMAB-RZAA |
| Application number | BLA761105 |
| Sponsor | ABBVIE INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20190423 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →